(BPT) - Ataxia, a rare and progressive neurological disease, affects nearly 150,000 people in the U.S. A new clinical study will measure if troriluzole, an investigational drug, will improve ataxia symptoms in people with spinocerebellar ataxia (SCA). Learn more at www.scatrial.org.

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.